# Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.

> **NCT02631148** · PHASE2 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 12 (actual)

## Conditions studied

- Obesity
- Prediabetic State

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02631148
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** International shortage of the chemical para-aminohippuric acid (PAH) due to manufacturing changes, led to inability to perform key measurements to meet trial objectives
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631148, "Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02631148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*